Amina Ibrahim Shehu

Amina Ibrahim Shehu

Auto-generated profile, based on publicly available information

Amina Ibrahim Shehu

Pharmacovigilance Department, National Agency for Food and Administration Control (NAFDAC), Abuja, Nigeria

Research Focus & Metrics

Academic Career Length

10Years (2017-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
4 June 2019 in Journal of Clinical Investigation
Verified
Journal Article
Open access
PDF file
ASAmina I. Shehu
Amina I. Shehu
JLJie Lu
Jie Lu
PWPengcheng Wang
Pengcheng Wang
JZJunjie Zhu
Junjie Zhu
YWYue Wang
Yue Wang
XMXiaochao Ma
Xiaochao Ma
Ritonavir (RTV) is on the World Health Organization’s list of essential medicines for antiretroviral therapy, but can cause hepatotoxicity by unknown mechanisms. Multiple clinical studies found that hepatotoxicity occurred in 100% of participants who were pretreated with rifampicin or efavirenz followed by RTV-containing regimens. Both rifampicin and efavirenz are activators of the pregnane X receptor (PXR), a transcription factor with marked interspecies differences in ligand-dependent activation. Using PXR-humanized mouse models, we recapitulated the RTV hepatotoxicity observed in the clinic. PXR was found to modulate RTV hepatotoxicity through CYP3A4-dependent pathways involved in RTV bioactivation, oxidative stress, and endoplasmic reticulum stress. In summary, the current work demonstrated the essential roles of human PXR and CYP3A4 in RTV hepatotoxicity, which can be applied to guide the safe use of RTV-containing regimens in the clinic.

6 September 2019 in Science Advances
Verified
Journal Article
Open access
PDF file
PWPengcheng Wang
Pengcheng Wang
MSMadhav Sachar
Madhav Sachar
JLJie Lu
Jie Lu
ASAmina I. Shehu
Amina I. Shehu
JZJunjie Zhu
Junjie Zhu
XMXiaochao Ma
Xiaochao Ma
The transporter ABCG2 determines phototoxicity and hepatotoxicity in erythropoietic protoporphyria.

3 January 2017 in Current Pharmacology Reports
Verified
Journal Article
Open access
PDF file
PWPengcheng Wang
Pengcheng Wang
ASAmina I. Shehu
Amina I. Shehu
XMXiaochao Ma
Xiaochao Ma
Although safety of drug candidates is carefully monitored in preclinical and clinical studies using a variety of approaches, drug toxicity may still occur in clinical practice. Therefore, novel approaches are needed to complement the current drug safety evaluation system. Metabolomics comprehensively analyzes the metabolites altered by drug exposure, which can therefore be used to profile drug metabolism, endobiotic metabolism, and drug-microbiota interactions. The information from metabolomic analysis can be used to determine the off-targets of a drug candidate and thus provide a mechanistic understanding of drug toxicity. We herein discuss the opportunities of metabolomics in drug safety evaluation.

4 June 2026 in BMC Pregnancy and Childbirth
Verified
Journal Article
Open access
FAFatima Inusa Anga
Fatima Inusa Anga
HBHabeebah T. Bakare
Habeebah T. Bakare
CIChris O. Ifediora
Chris O. Ifediora
HAHalima Inusa Anga
Halima Inusa Anga
ASAminat Suleman-Alabi
Aminat Suleman-Alabi
TSTijani Salami
Tijani Salami
Coronavirus disease 2019 (COVID-19) is a respiratory tract infection caused by severe acute respiratory syndrome coronavirus (SARS-CoV-2). Pregnant women are particularly vulnerable to COVID-19 due to physiological and immunological changes in pregnancy. Understanding their knowledge and preventive practices is essential for guiding maternal-health interventions. This study assessed the knowledge, perceptions, and adoption of preventive measures against COVID-19 among pregnant women attending antenatal care at the Federal Medical Centre (FMC), Jabi, Abuja. A descriptive cross-sectional study was conducted from July to September 2021 among pregnant women selected through multistage sampling. Using a structured, interviewer-administered questionnaire we obtained data on knowledge, perceptions and preventive practices from 120 women participated. Data was analyzed using SPSS version 28 and summarized as descriptive statistics. Awareness of COVID-19 was high (95.8%) among pregnant women. Most respondents demonstrated adequate knowledge of transmission and prevention, including hand hygiene (99.2%), avoidance of crowds (92.5%), and isolation measures (90.0%). Misconceptions persisted, particularly regarding breastfeeding. Only 35.0% agreed that COVID-19 positive mothers can safely breastfeed, while 42.5% were unsure. Vaccine willingness was moderate (54.2%), reflecting hesitancy despite overall good knowledge. We found high level of awareness and generally positive preventive attitudes toward COVID-19 among pregnant women, but gaps remain in breastfeeding knowledge and vaccine acceptance. Targeted health education and strengthened ANC counselling are needed to address misconceptions and support consistent adoption of preventive practices.